US EditionFDA's Drug Chief Resigns Three Weeks After Appointment
Richard Pazdur retired after 26 years at the FDA, citing political interference concerns, leaving leadership gaps at the Center for Drug Evaluation and Research and Oncology Center of Excellence.
- On November 11, Dr. Richard Pazdur was named director of the Center for Drug Evaluation and Research, then filed to retire weeks later with the FDA confirming paperwork for an end-of-December exit, Stat News first reported.
- People familiar with the decision said Pazdur balked at political interference in the drug division, and his exit followed frustration involving FDA Commissioner Marty Makary and Dr. Vinay Prasad.
- A longtime FDA official, Pazdur transformed cancer drug regulation, founding the Oncology Center of Excellence in 2017 and leading initiatives to streamline approvals while ensuring evidence standards.
- His retirement would leave vacancies at both CDER and the Oncology Center of Excellence, and stocks of biotechnology companies fell Tuesday morning amid added sector uncertainty.
- Analysts point out rising delays and unpredictability, and drug developers and industry watchers say Pazdur's potential successor must have solid regulatory or industry experience.
33 Articles
33 Articles
Top FDA Drug Regulator Departing After Weeks in Position
One of the Food and Drug Administration’s top officials is departing the agency, a spokesperson confirmed on Dec. 2. Dr. Richard Pazdur will be retiring, an FDA spokesperson told The Epoch Times in an email. “We respect Dr. Pazdur’s decision to retire and honor his 26 years of distinguished service at the FDA,” the spokesperson said. “As the founding director of the Oncology Center of Excellence, he leaves a legacy of cross-center regulatory inn…
FDA’s top drug officer set to retire after weeks in job
Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug Administration lead drug regulator Richard Pazdur will resign, despite being only weeks into his job. Pazdur was the founding director of the Oncology Center of Excellence and served with the FDA for 26 years. Marty Markary, the
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
